Smoking-related gene expression in laser capture-microdissected human lung

Clinical Cancer Research

Volumn 15, Issue 24, 2009, Pages 7562-7570

  Tan, Xiang Lin ^a   Wang, Tao ^a   Xiong, Shengli ^a,b   Kumar, Shalini V ^b   Han, Weiguo ^a,b   Spivack, Simon D ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COTININE; CYTOCHROME P450 1B1; CYTOCHROME P450 2A; CYTOCHROME P450 2A13; GLUTATHIONE TRANSFERASE P1; MESSENGER RNA; NICOTINE; PROTEIN P16; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHUS MUCOSA; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; EXPOSURE; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LUNG ALVEOLUS; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; METABOLISM; OCCUPATIONAL HAZARD; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE TRAIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SMOKE; SMOKING; TOBACCO; TUMOR SUPPRESSOR GENE;

EID: 73349096889     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-1694     Document Type: Article

References (48)

1. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001;98: 13784-9.
2. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001;98:13790-5.
3. Singhal S, Miller D, Ramalingam S, Sun SY. Gene expression profiling of non-small cell lung cancer. Lung Cancer 2008;60:313-24.
4. Lacroix L, Commo F, Soria JC. Gene expression profiling of non-small-cell lung cancer. Expert Rev Mol Diagn 2008;8:167-78.
5. Beane J, Spira A, Lenburg ME. Clinical impact of high-throughput gene expression studies in lung cancer. J Thorac Oncol 2009;4:109-18.
6. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-6.
7. Zhang X, Liu G, Lenburg ME, Spira A. Comparison of smoking-induced gene expression on Affymetrix Exon and 3′-based expression arrays. Genome Inform 2007;18:247-57.
8. Carolan BJ, Harvey BG, De BP, Vanni H, Crystal RG. Decreased expression of intelectin 1 in the human airway epithelium of smokers compared to nonsmokers. J Immunol 2008;181: 5760-7.
9. Harvey BG, Heguy A, Leopold PL, Carolan BJ, Ferris B, Crystal RG. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J Mol Med 2007; 85:39-53.
10. Landi MT, Dracheva T, Rotunno M, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS ONE 2008;3:e1651.
11. Gillespie JW, Gannot G, Tangrea MA, et al. Molecular profiling of cancer. Toxicol Pathol 2004;32 Suppl 1:67-71.
12. Willey JC, Coy E, Brolly C, et al. Xenobiotic metabolism enzyme gene expression in human bronchial epithelial and alveolar macrophage cells. Am J Respir Cell Mol Biol 1996;14:262-71.
13. Have-Opbroek AA, Benfield JR, van Krieken JH, Dijkman JH. The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol 1997;12:319-36.
14. Otto WR. Lung epithelial stem cells. J Pathol 2002;197:527-35.
15. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005;121: 823-35.
16. Miura K, Bowman ED, Simon R, et al. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 2002;62:3244-50.
17. Kobayashi K, Nishioka M, Kohno T, et al. Identification of genes whose expression is upregulated in lung adenocarcinoma cells in comparison with type II alveolar cells and bronchiolar epithelial cells in vivo. Oncogene 2004; 23:3089-96.
18. Nakamura N, Kobayashi K, Nakamoto M, et al. Identification of tumor markers and differentiation markers for molecular diagnosis of lung adenocarcinoma. Oncogene 2006;25:4245-55.
19. Rohrbeck A, Neukirchen J, Rosskopf M, et al. Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med 2008;6:69.
20. Hurteau GJ, Spivack SD. mRNA-specific reverse transcription-polymerase chain reaction from human tissue extracts. Anal Biochem 2002;307:304-15.
21. Spivack SD, Hurteau GJ, Fasco MJ, Kaminsky LS. Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res 2003;9:6002-11.
22. Spivack SD, Hurteau GJ, Reilly AA, Aldous KM, Ding X, Kaminsky LS. CYP1B1 expression in human lung. Drug Metab Dispos 2001;29: 916-22.
23. Roos PH, Bolt HM. Cytochrome P450 interactions in human cancers: new aspects considering CYP1B1. Expert Opin Drug Metab Toxicol 2005;1:187-202.
24. Su T, Bao Z, Zhang QY,Smith TJ, Hong JY, Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobaccospecific carcinogen, 4-(methylnitrosamino)-1- (3-pyridyl)-1-butanone. Cancer Res 2000;60:5074-9.
25. Zhu LR, Thomas PE, Lu G, et al. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptidespecific antibody. Drug Metab Dispos 2006;34: 1672-6.
26. Zhang X, D'Agostino J, Wu H, et al. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J Pharmacol Exp Ther 2007;323: 570-8.
27. Jalas JR, Hecht SS, Murphy SE. Cytochrome P450 enzymes as catalysts of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Chem Res Toxicol 2005;18:95-110.
28. Spivack SD, Hurteau GJ, Jain R, et al. Geneenvironment interaction signatures by quantitative mRNA profiling in exfoliated buccal mucosal cells. Cancer Res 2004;64:6805-13.
29. Coles B, Yang M, Lang NP, Kadlubar FF. Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8- diol-9,10-oxide. Cancer Lett 2000;156:167-75.
30. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR. Increased skin tumorigenesis in mice lacking π class glutathione S-transferases. Proc Natl Acad Sci U S A 1998;95: 5275-80.
31. Gate L, Majumdar RS, Lunk A,TewKD. Influence of glutathione S-transferase π and p53 expression on tumor frequency and spectrum in mice. Int J Cancer 2005;113:29-35.
32. Ritchie KJ, Henderson CJ, Wang XJ, et al. Glutathione transferase π plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res 2007;67:9248-57.
33. Wright GS, Gruidl ME. Early detection and prevention of lung cancer. Curr Opin Oncol 2000;12: 143-8.
34. Davis RA. The determination of nicotine and cotinine in plasma. J Chromatogr Sci 1986;24: 134-41.
35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ÄÄ C(T)) Method. Methods 2001;25:402-8.
37. Spira A, Beane J, Shah V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc Natl Acad Sci U S A 2004; 101:10143-8.
38. Lampe JW, Stepaniants SB, Mao M, et al. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 2004;13:445-53.
39. Willey JC, Coy EL, Frampton MW, et al. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 1997;17:114-24.
40. Kyerematen GA, Taylor LH, deBethizy JD, Vesell ES. Pharmacokinetics of nicotine and 12 metabolites in the rat. Application of a new radiometric high performance liquid chromatography assay. Drug Metab Dispos 1988; 16:125-9.
41. JarvisMJ,RussellMA, BenowitzNL, Feyerabend C. Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure. Am J Public Health 1988; 78:696-8.
42. Foth H, Looschen H, Neurath H, Kahl GF. Nicotine metabolism in isolated perfused lung and liver of phenobarbital- and benzoflavonetreated rats. Arch Toxicol 1991;65:68-72.
43. Green JT, Evans BK, Rhodes J, et al. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics. Br J Clin Pharmacol 1999; 48:485-93.
44. Cantlay AM, Smith CA, Wallace WA, Yap PL, Lamb D, Harrison DJ. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax 1994;49: 1010-4.
45. Han W, Pentecost BT, Pietropaolo RL, Fasco MJ, Spivack SD. Estrogen receptor α increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog 2005;44:202-11.
46. Cauchi S, Han W, Kumar SV, Spivack SD. Haplotype-environment interactions that regulate the human glutathione S-transferase P1 promoter. Cancer Res 2006;66:6439-48.
47. Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene 1998;16:497-504.
48. Groeger AM, Caputi M, Esposito V, et al. Independent prognostic role of p16 expression in lung cancer. J Thorac Cardiovasc Surg 1999; 118:529-35.